Your browser doesn't support javascript.
loading
Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015).
Bliss, Judith M; Tovey, Holly; Evans, Abigail; Holcombe, Chris; Horgan, Kieran; Mallon, Elizabeth; Vidya, Raghavan; Skene, Anthony; Dodson, Andrew; Hills, Margaret; Detre, Simone; Zabaglo, Lila; Banerji, Jane; Kilburn, Lucy; Morden, James P; Robertson, John F R; Smith, Ian; Dowsett, Mitch.
Afiliación
  • Bliss JM; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK. Judith.bliss@icr.ac.uk.
  • Tovey H; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK.
  • Evans A; Poole Hospital, Poole, UK.
  • Holcombe C; Royal Liverpool University Hospital, Liverpool, UK.
  • Horgan K; Department of Breast Surgery, St James's University Hospital, Leeds, UK.
  • Mallon E; Western Infirmary, Glasgow, UK.
  • Vidya R; Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Skene A; Royal Bournemouth Hospital, Bournemouth, UK.
  • Dodson A; UK NEQAS for Immunocytochemistry and In-Situ Hybridisation, London, UK.
  • Hills M; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, and Breast Cancer Now Centre, The Institute of Cancer Research, London, UK.
  • Detre S; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, and Breast Cancer Now Centre, The Institute of Cancer Research, London, UK.
  • Zabaglo L; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, and Breast Cancer Now Centre, The Institute of Cancer Research, London, UK.
  • Banerji J; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK.
  • Kilburn L; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK.
  • Morden JP; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK.
  • Robertson JFR; Royal Derby Hospital, University of Nottingham, Derby, UK.
  • Smith I; Breast Unit, Royal Marsden Hospital, London, UK.
  • Dowsett M; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, and Breast Cancer Now Centre, The Institute of Cancer Research, London, UK.
Breast Cancer Res ; 25(1): 39, 2023 04 12.
Article en En | MEDLINE | ID: mdl-37046348
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de la Aromatasa Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de la Aromatasa Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido